AN APPROACH FOR DESIGNING OF TRANSDERMAL PATCHES FOR PROPHYLAXIS AND TREATMENT OF HIV/AIDS by Gupta, Ravikant et al.
Gupta et al                                                                                                              Journal of Drug Delivery & Therapeutics. 2017; 7(7):21-22                       
ISSN: 2250-1177                                                                                [21]                                                                             CODEN (USA): JDDTAO 
Available online on 25.12.2017 at http://jddtonline.info 
Journal of Drug Delivery and Therapeutics 
Open Access to Pharmaceutical and Medical Research 
© 2011-17, publisher and licensee JDDT, This is an Open Access article which permits unrestricted non-
commercial use, provided the original work is properly cited 
Open  Access                                                                                                                     Research Article 
AN APPROACH FOR DESIGNING OF TRANSDERMAL PATCHES FOR 
PROPHYLAXIS AND TREATMENT OF HIV/AIDS 
Ravikant Gupta
1
, Alok Pal Jain
1
, Akash Yadav
2
, Awdhesh Maheshwari
3
 
1
Institute of Science & Technology, SRK University, NH-12, Hoshangabad Road, Misrod, Bhopal, M.P., India 
2
IPS Academy College of Pharmacy, A.B. Road, Rajendra Nagar, Indore, Madhya Pradesh, India 
3
Mylan Laboratories Limited, Pithampur Industrial Area, Kalibillod, Pithampur, Madhya Pradesh, India 
E-mail address:ravikant491990@gmail.com 
 
ABSTRACT 
Transdermal drug delivery is an alternative route for systemic drug delivery system, which minimizes the absorption of drugs and 
increases the bioavailability through systemic circulation. Currently available anti-HIV drugs bear some significant drawbacks, such 
as relatively short half life, low bioavailability, poor permeability and undesirable side effects. The purpose of this work is to 
formulate and evaluate transdermal drug delivery system of anti-HIV drug using various polymers such as HPMC, PVP and ethyl 
cellulose by solvent evaporation technique for improvement of bioavailability of drug and reducing toxic effects. By this mean we 
can achieve dosage form with reduce dosing frequency,  increase the bioavailability, decrease the degradation and metabolism in the 
gastrointestinal tract, improve the CNS penetration and inhibit the CNS efflux and deliver them to the target cells effectively with 
minimal side effects. This paper provides details of preformulation study, drug selection criteria, formulation strategies, evaluation 
perspective, Stability approaches for sustain drug release kinetics. 
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INTRODUCTION: 
Acquired immunodeficiency syndrome (AIDS), caused 
by human immunodeficiency virus (HIV) is an 
immunosuppressive disease that results in life-
threatening opportunistic infections and malignancies. 
HIV infection is one of the major threats to human 
health’s due to lack of relevant vaccine and drugs to cure 
AIDS.There are lots of drugs and dosage forms in 
combination & sustain delivery forms are available in 
the market but failed to achieve targeting. In this era 
many scientists working on target drug delivery for 
ARV. Even novel formulations are also in 
developmental stages. In this work we will discuss about 
novel formulations in the form of Transdermal patches 
for ARV drugs
1
. 
The numerous administrations of several drugs in 
moderately high doses are a main cause of patient 
incompliance and hurdle towards the fulfillment of the 
pharmacotherapy. Intracellular and anatomical viral 
reservoirs are accountable for the perpetuation of the 
infection. Active transport mechanisms involving 
proteins of the ATP binding cassette super family 
prevent the penetration of ARV drugs into the brain and 
may account for the inadequate bioavailability after oral 
administration. The proposed work is aimed to formulate 
and characterize the transdermal patches of antiretroviral 
drugs for efficient transdermal delivery of drug in 
pharmaceutical system
2, 3
. 
MATERIALS AND METHODS: 
Materials for the study are: Drug, Polymers (Poly vinyl 
pyrolidine, Hydroxyl Propel methyl cellulose and ethyl 
cellulose) other chemicals are Analytical grade reagents. 
Method for preparation of the Transdermal patches will 
be solvent evaporation/Solvent casting method. Below 
mentioned steps will follow for experimentation: 
 Selection of Drug and Exicipients 
 Preformulation Study 
A concise stepwise account of the various tasks that 
need to be executed for successful accomplishment of 
the research envisaged. 
Analytical method selection 
 UV-VIS spectrophotometer 
 FTIR 
UV-VIS spectrophotometry is suitable for initial 
screening studies as the method is convenient and less 
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time consuming. Both qualitative and quantitative 
estimations can be performed. 
FTIR is a good method for estimating drug excipient 
interactions. Qualitative estimations can be very well 
carried out 
 Solubility studies 
 Partition coefficient  
 For estimation of solubility, partition coefficient etc. 
solvent selection UV-VIS spectrophotometry 
method used. 
o Assay method  
o Melting point 
o pH analysis 
o Drug-excipient interaction study 
 Formulation development 
 Trial batch formulations for preparation of free 
films 
 Preparation of medicated films 
 Evaluation 
The prepared medicated films will be evaluated 
for: 
 Thickness 
 Weight variation 
 Percent flatness 
 Moisture content 
 Moisture uptake 
 Tensile strength 
 Modulus of elasticity 
 Percent elongation 
 Drug content 
 Area variation 
 Folding endurance 
 In vitro performance 
 In vitro dissolution studies  
 In vitro permeation studies 
 In vitro- In vivo correlation study 
 Bioavailability Study 
 Analysis of permeation data 
 Data analysis 
 Skin irritation test in animal models. 
 Stability Study 
RESULTS AND DISCUSSION: 
In this work an attempt is to formulate transdermal 
patches for sustained release of antiretroviral drug by 
solvent casting method. An ideal dosage regimen in the 
drug therapy of any disease is one, which immediately 
attains the desired therapeutic concentration of drug in 
plasma (or at the site of action) and maintains it constant 
for prolong period of time. Transdermal drug delivery 
overcomes the number of drawbacks associated with 
conventional dosage drug delivery system. The main 
objective of formulating the transdermal system is to 
prolong the drug release time, reduce the frequency of 
administration and to improve patient compliance. 
Therefore an ideal controlled drug delivery system is the 
one, which delivers the drug at a predominant rate, 
locally or systematically, for a specific period of time. In 
this study, it is intended that the side effects and of the 
oral administration of elected drug be   overcome by 
delivering drug transdermally and bioavailability will 
also improve. 
CONCLUSION: 
In this study an attempt to make transdermal patches an 
alternative dosage form against conventional medication 
for the Anti retroviral drugs. Transdermal drug delivery 
overcomes the number of drawbacks associated with 
conventional dosage drug delivery system. The main 
objective of formulating the transdermal system is to 
prolong the drug release time, reduce the frequency of 
administration and to improve patient compliance. 
Preformulation study reflects the suitability of the drug 
selection and drug exipient study shows the 
compatibility of the drug in dosage forms and stability 
study will reflects the shelf life of the drug. From In 
vitro- in vivo models we can conclude the effective 
delivery of drug. 
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